FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Avraham Raz

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Anatomy

Physiology

Disorders

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Vitaly Balan; Madhuri Bajaj; Lance Heilbrun; Dhong Hyo Kho; Pratima Nangia-Makker; Avraham Raz; Daryn Smith; Yi Wang; Elisabeth Heath
Galectin-3: a possible complementary marker to the PSA blood test.
Dhong Hyo Kho; Pratima Nangia-Makker; Vitaly Balan; Victor Hogan; Larry Tait; Yi Wang; Avraham Raz
Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells.
Aamir Ahmad; Alia Ahmed; Azfur S Ali; Shadan Ali; Avraham Raz; Wael A Sakr; K M Wahidur Rahman
3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Avraham Raz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vitaly Balan; Madhuri Bajaj; Lance Heilbrun; Dhong Hyo Kho; Pratima Nangia-Makker; Avraham Raz; Daryn Smith; Yi Wang; Elisabeth Heath
Galectin-3: a possible complementary marker to the PSA blood test.
Oncotarget 2013;4(4):542-9.
2013: Dhong Hyo Kho; Pratima Nangia-Makker; Vitaly Balan; Victor Hogan; Larry Tait; Yi Wang; Avraham Raz
Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells.
Cancer research 2013;73(4):1411-9.
2013: Aamir Ahmad; Alia Ahmed; Azfur S Ali; Shadan Ali; Avraham Raz; Wael A Sakr; K M Wahidur Rahman
3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cells.
PloS one 2013;8(1):e54657.
2012: Russell R Braeuer; Woonyoung Choi; Andrey S Dobroff; Li Huang; Takafumi Kamiya; David J McConkey; Aaron K Mobley; Avraham Raz; Einav Shoshan; Renduo Song; Maya Zigler; Menashe Bar-Eli
Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.
Cancer research 2012;72(22):5757-66.
2012: Takashi Yanagawa; Hideomi Watanabe; Avraham Raz; Kenichi Saito; Tetsuya Shinozaki; Kenji Takagishi
Vascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomas.
Experimental cell research 2012;318(7):800-8.
2012: Vitaly Balan; Dhong Hyo Kho; Pratima Nangia-Makker; Yi Wang; Avraham Raz
Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage.
The Journal of biological chemistry 2012;287(8):5192-8.
2012: Pratima Nangia-Makker; Vitaly Balan; Avraham Raz
Galectin-3 binding and metastasis.
Methods in molecular biology (Clifton, N.J.) 2012;878():251-66.
2011: Tsutomu Kobayashi; Norio Kubo; Hiroyuki Kuwano; Tatsuo Shimura; Hideki Suzuki; Soichi Tsutsumi; Toshiki Yajima; Kenichiro Araki; Avraham Raz
Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.
International journal of cancer. Journal international du cancer 2011;129(12):2775-86.
2011: Aamir Ahmad; Ashhar S Ali; Shadan Ali; Avraham Raz; Wael A Sakr; Seema Sethi; Zhiwei Wang; K M Wahidur Rahman
3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.
International journal of cancer. Journal international du cancer 2011;129(7):1781-91.
2011: Aamir Ahmad; Amro Aboukameel; Dejuan Kong; Zhiwei Wang; Seema Sethi; Wei Chen; Asfar S Azmi; Avraham Raz
Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Cancer research 2011;71(9):3400-9.
2011: Tsutomu Kobayashi; Tatsuo Shimura; Toshiki Yajima; Norio Kubo; Kenichiro Araki; Wataru Wada; Soichi Tsutsumi; Hideki Suzuki; Hiroyuki Kuwano; Avraham Raz
Transient silencing of galectin-3 expression promotes both in vitro and in vivo drug-induced apoptosis of human pancreatic carcinoma cells.
Clinical & experimental metastasis 2011;28(4):367-76.
2011: Ran Levy; Francoise Poirier; Avraham Raz; Anat Biran; Yoel Kloog
Galectin-3 mediates cross-talk between K-Ras and Let-7c tumor suppressor microRNA.
PloS one 2011;6(11):e27490.
2010: Pratima Nangia-Makker; Yi Wang; Tirza Raz; Larry Tait; Vitaly Balan; Victor Hogan; Avraham Raz
Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer.
International journal of cancer. Journal international du cancer 2010;127(11):2530-41.
2010: Yasufumi Niinaka; Kiyoshi Harada; Masahiro Fujimuro; Masamitsu Oda; Arayo Haga; Misa Hosoki; Narikazu Uzawa; Naoya Arai; Satoshi Yamaguchi; Masashi Yamashiro; Avraham Raz
Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
Cancer research 2010;70(22):9483-93.
2010: Vitaly Balan; Pratima Nangia-Makker; Young Suk Jung; Yi Wang; Avraham Raz
Galectin-3: A novel substrate for c-Abl kinase.
Biochimica et biophysica acta 2010;1803(10):1198-205.
2010: Y Wang; Pratima Nangia-Makker; V Balan; Victor Hogan; Avraham Raz
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment.
Cell death & disease 2010;1():e101.
2009: Kenichiro Araki; Tatsuo Shimura; Toshiki Yajima; Soichi Tsutsumi; Hideki Suzuki; Kohji Okada; Tsutomu Kobayashi; Avraham Raz; Hiroyuki Kuwano
Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
The Journal of biological chemistry 2009;284(47):32305-11.
2009: Vladislav V Glinsky; Avraham Raz
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets.
Carbohydrate research 2009;344(14):1788-91.
2009: Tatsuyoshi Funasaka; Victor Hogan; Avraham Raz
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Cancer research 2009;69(13):5349-56.
2009: Yi Wang; Pratima Nangia-Makker; Larry Tait; Vitaly Balan; Victor Hogan; Kenneth J Pienta; Avraham Raz
Regulation of prostate cancer progression by galectin-3.
The American journal of pathology 2009;174(4):1515-23.
2009: He-Yu Zhang; Long Jin; Gail A Stilling; Katharina H Ruebel; Kendra Coonse; Yoshinori Tanizaki; Avraham Raz; Ricardo V Lloyd
RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors.
Endocrine 2009;35(1):101-11.
2008: Vitaly Balan; Pratima Nangia-Makker; Ann Grossbart Schwartz; Young Suk Jung; Larry Tait; Victor Hogan; Tirza Raz; Yi Wang; Zeng-Quan Yang; Gen Sheng Wu; Yongjun Guo; Huixiang Li; Judith Abrams; Fergus J. Couch; Wilma L Lingle; Ricardo V Lloyd; Stephen Ethier; Michael A Tainsky; Avraham Raz
Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.
Cancer research 2008;68(24):10045-50.
2008: Pratima Nangia-Makker; Vitaly Balan; Avraham Raz
Regulation of tumor progression by extracellular galectin-3.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society 2008;1(1):43-51.
2008: Alexandra Mourad; Vladislava O Melnikova; Hua Wang; Avraham Raz; Menashe Bar-Eli
Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
The American journal of pathology 2008;173(6):1839-52.
2008: Hidenori Inohara; Tatsuya Segawa; Akira Miyauchi; Tadashi Yoshii; Susumu Nakahara; Avraham Raz; Masahiro Maeda; Eiji Miyoshi; Noriaki Kinoshita; Hiroshi Yoshida; Masashi Furukawa; Yukinori Takenaka; Yuki Takamura; Yasuhiro Ito; Naoyuki Taniguchi
Cytoplasmic and serum galectin-3 in diagnosis of thyroid malignancies.
Biochemical and biophysical research communications 2008;376(3):605-10.
2008: Arayo Haga; Tatsuyoshi Funasaka; Yoshihiro Deyashiki; Avraham Raz
Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.
FEBS letters 2008;582(13):1877-82.
2008: Ruby Shalom-Feuerstein; Ran Levy; Victoria Makovski; Avraham Raz; Yoel Kloog
Galectin-3 regulates RasGRP4-mediated activation of N-Ras and H-Ras.
Biochimica et biophysica acta 2008;1783(6):985-93.
2008: Susumu Nakahara; Avraham Raz
Biological modulation by lectins and their ligands in tumor progression and metastasis.
Anti-cancer agents in medicinal chemistry 2008;8(1):22-36.
2007: Pratima Nangia-Makker; Tirza Raz; Larry Tait; Victor Hogan; Rafael Fridman; Avraham Raz
Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.
Cancer research 2007;67(24):11760-8.
2007: Tatsuyoshi Funasaka; Huankai Hu; Victor Hogan; Avraham Raz
Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence.
The Journal of biological chemistry 2007;282(50):36362-9.
2007: Tatsuyoshi Funasaka; Avraham Raz
The role of autocrine motility factor in tumor and tumor microenvironment.
Cancer metastasis reviews 2007;26(3-4):725-35.
2007: Susumu Nakahara; Avraham Raz
Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway.
Cancer metastasis reviews 2007;26(3-4):605-10.
2007: K M Wahidur Rahman; Shadan Ali; Amro Aboukameel; Sarah H Sarkar; Zhiwei Wang; Philip A Philip; Wael A Sakr; Avraham Raz
Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Molecular cancer therapeutics 2007;6(10):2757-65.
2007: Takashi Yanagawa; Tatsuyoshi Funasaka; Soichi Tsutsumi; Huankai Hu; Hideomi Watanabe; Avraham Raz
Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Cancer research 2007;67(18):8682-9.
2007: Pratima Nangia-Makker; Larry Tait; Malathy Puthan Veedu Shekhar; Eduardo Palomino; Victor Hogan; Marie P Piechocki; Tatsuyoshi Funasaka; Avraham Raz
Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum.
International journal of cancer. Journal international du cancer 2007;121(4):884-94.
2007: Kim D Johnson; Olga V Glinskii; Valeri V Mossine; James Turk; thomas mawhinney; Douglas C Anthony; Carolyn J Henry; V. H. Huxley; Gennadi V Glinsky; Kenneth J Pienta; Avraham Raz; Vladislav V Glinsky
Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.
Neoplasia (New York, N.Y.) 2007;9(8):662-70.
2007: Nachman Mazurek; Yun Jie Sun; Kai-Feng Liu; Michael Z Gilcrease; Wendy D Schober; Pratima Nangia-Makker; Avraham Raz; Robert S Bresalier
Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells.
The Journal of biological chemistry 2007;282(29):21337-48.
2007: Tomoharu Fukumori; Hiro-Omi Kanayama; Avraham Raz
The role of galectin-3 in cancer drug resistance.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(3):101-8.
2007: Heather M McClung; Stacey L Thomas; Pamela Osenkowski; Marta Toth; Priya Menon; Avraham Raz; Rafael Fridman; Sandra Rempel
SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
Neuroscience letters 2007;419(2):172-7.
2007: Tatsuyoshi Funasaka; Huankai Hu; Takashi Yanagawa; Victor Hogan; Avraham Raz
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Cancer research 2007;67(9):4236-43.
2007: James Edward Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Murine models to evaluate novel and conventional therapeutic strategies for cancer.
The American journal of pathology 2007;170(3):793-804.
2007: Pratima Nangia-Makker; Susumu Nakahara; Victor Hogan; Avraham Raz
Galectin-3 in apoptosis, a novel therapeutic target.
Journal of bioenergetics and biomembranes 2007;39(1):79-84.
2006: Susumu Nakahara; Victor Hogan; Hidenori Inohara; Avraham Raz
Importin-mediated nuclear translocation of galectin-3.
The Journal of biological chemistry 2006;281(51):39649-59.
2006: Kate Shen; Yaolin Wang; Sam C Brooks; Avraham Raz; Y Alan Wang
ATM is activated by mitotic stress and suppresses centrosome amplification in primary but not in tumor cells.
Journal of cellular biochemistry 2006;99(5):1267-74.
2006: Victor G Prieto; Alexandra Mourad; Vladislava O Melnikova; Marcella M Johnson; Adriana Lopez; A Hafeez Diwan; Alexander Lazar; Steven S Shen; Peter S Zhang; Jon A Reed; jeffrey gershenwald; Avraham Raz; Menashe Bar-Eli
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(22):6709-15.
2006: Susumu Nakahara; Natsuo Oka; Yi Wang; Victor Hogan; Hidenori Inohara; Avraham Raz
Characterization of the nuclear import pathways of galectin-3.
Cancer research 2006;66(20):9995-10006.
2006: Arayo Haga; Sachiko Komazaki; Tatsuyoshi Funasaka; Kazunori Hashimoto; Yuichi Yokoyama; Hideomi Watanabe; Avraham Raz; Hisamitsu Nagase
AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78.
Leukemia & lymphoma 2006;47(10):2234-43.
2006: Kate C Shen; Fred R Miller; Larry Tait; Steven J Santner; Robert Pauley; Avraham Raz; Michael A Tainsky; Sam C Brooks; Y Alan Wang
Isolation and characterization of a breast progenitor epithelial cell line with robust DNA damage responses.
Breast cancer research and treatment 2006;98(3):357-64.
2006: Arayo Haga; Nobutada Tanaka; Tatsuyoshi Funasaka; Kazunori Hashimoto; Kazuo T Nakamura; Hideomi Watanabe; Avraham Raz; Hisamitsu Nagase
The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Journal of molecular biology 2006;358(3):741-53.
2006: Annick Lagana; Jacky G Goetz; Pam Cheung; Avraham Raz; James W Dennis; Ivan R Nabi
Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells.
Molecular and cellular biology 2006;26(8):3181-93.
2006: Tomoharu Fukumori; Natsuo Oka; Yukinori Takenaka; Pratima Nangia-Makker; Essam Elsamman; Toshinori Kasai; Masayuki Shono; Hiro-Omi Kanayama; Julie A Ellerhorst; Reuben Lotan; Avraham Raz
Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer.
Cancer research 2006;66(6):3114-9.
2006: Nobutada Tanaka; Arayo Haga; Noriko Naba; Katsura Shiraiwa; Yoshio Kusakabe; Kazunori Hashimoto; Tatsuyoshi Funasaka; Hisamitsu Nagase; Avraham Raz; Kazuo T Nakamura
Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
Journal of molecular biology 2006;356(2):312-24.
2006: Wen Jiang; Avraham Raz; Anthony Douglas-Jones; Robert E Mansel
Expression of autocrine motility factor (AMF) and its receptor, AMFR, in human breast cancer.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006;54(2):231-41.
2006: Susumu Nakahara; Avraham Raz
On the role of galectins in signal transduction.
Methods in enzymology 2006;417():273-89.
2006: Yoh Dobashi; Hideomi Watanabe; Maki Matsubara; Takashi Yanagawa; Avraham Raz; Tamiyasu Shimamiya; Akishi Ooi
Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours.
The Journal of pathology 2006;208(1):44-53.
2005: Nachman Mazurek; Yun Jie Sun; Janet E Price; Latha Ramdas; Wendy D Schober; Pratima Nangia-Makker; James C Byrd; Avraham Raz; Robert S Bresalier
Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
Cancer research 2005;65(23):10767-75.
2005: Natsuo Oka; Susumu Nakahara; Yukinori Takenaka; Tomoharu Fukumori; Victor Hogan; Hiro-Omi Kanayama; Takashi Yanagawa; Avraham Raz
Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
Cancer research 2005;65(17):7546-53.
2005: Tatsuyoshi Funasaka; Takashi Yanagawa; Victor Hogan; Avraham Raz
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(11):1422-30.
2005: Ruby Shalom-Feuerstein; Tomer Cooks; Avraham Raz; Yoel Kloog
Galectin-3 regulates a molecular switch from N-Ras to K-Ras usage in human breast carcinoma cells.
Cancer research 2005;65(16):7292-300.
2005: Kamil Kaynak; M Kara; Buge Oz; B Akgoz; Mehmet Sar; Avraham Raz
Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
Acta chirurgica Belgica 2005;105(4):378-82.
2005: Avraham Raz
Sugar recognition and metastasis: from birth of a research field to the clinic.
Cancer biology & therapy 2005;4(6):679-81.
2005: Olga V Glinskii; V. H. Huxley; Gennadi V Glinsky; Kenneth J Pienta; Avraham Raz; Vladislav V Glinsky
Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs.
Neoplasia (New York, N.Y.) 2005;7(5):522-7.
2005: Tatsuo Shimura; Yukinori Takenaka; Tomoharu Fukumori; Soichi Tsutsumi; Kohji Okada; Victor Hogan; Akira Kikuchi; Hiroyuki Kuwano; Avraham Raz
Implication of galectin-3 in Wnt signaling.
Cancer research 2005;65(9):3535-7.
2005: Takashi Yanagawa; Tatsuyoshi Funasaka; Soichi Tsutsumi; Tirza Raz; Nobutada Tanaka; Avraham Raz
Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
The Journal of biological chemistry 2005;280(11):10419-26.
2005: Susumu Nakahara; Natsuo Oka; Avraham Raz
On the role of galectin-3 in cancer apoptosis.
Apoptosis : an international journal on programmed cell death 2005;10(2):267-75.
2005: Katharina H Ruebel; Long Jin; Xiang Qian; Bernd W Scheithauer; Kalman Kovacs; Nobuki Nakamura; Heyu Zhang; Avraham Raz; Ricardo V Lloyd
Effects of DNA methylation on galectin-3 expression in pituitary tumors.
Cancer research 2005;65(4):1136-40.
2004: Takashi Yanagawa; Tatsuyoshi Funasaka; Soichi Tsutsumi; H Watanabe; Avraham Raz
Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Endocrine-related cancer 2004;11(4):749-59.
2004: Malathy Puthan Veedu Shekhar; Pratima Nangia-Makker; Larry Tait; Fred R Miller; Avraham Raz
Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.
The American journal of pathology 2004;165(6):1931-41.
2004: Soichi Tsutsumi; Takashi Yanagawa; Tatsuo Shimura; Hiroyuki Kuwano; Avraham Raz
Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7775-84.
2004: Noriko Naba; Nobutada Tanaka; Katsura Shiraiwa; Yoshio Kusakabe; Tatsuyoshi Funasaka; Arayo Haga; Hisamitsu Nagase; Avraham Raz; Kazuo T Nakamura
Crystallization and preliminary X-ray crystallographic studies of mouse autocrine motility factor.
Acta crystallographica. Section D, Biological crystallography 2004;60(Pt 11):2084-6.
2004: Avraham Raz
Dystroglycan: to adhere or not adhere during cancer progression.
Cancer biology & therapy 2004;3(10):976.
2004: Tatsuo Shimura; Yukinori Takenaka; Souichi Tsutsumi; Victor Hogan; Akira Kikuchi; Avraham Raz
Galectin-3, a novel binding partner of beta-catenin.
Cancer research 2004;64(18):6363-7.
2004: Tomoharu Fukumori; Yukinori Takenaka; Natsuo Oka; Tadashi Yoshii; Victor Hogan; Hidenori Inohara; Hiro-Omi Kanayama; Hyeong-Reh Choi Kim; Avraham Raz
Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways.
Cancer research 2004;64(10):3376-9.
2004: Jin-Hyuk Choi; Kyung-Hee Chun; Avraham Raz; Reuben Lotan
Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3.
Cancer biology & therapy 2004;3(5):447-52.
2004: Yukinori Takenaka; Tomoharu Fukumori; Tadashi Yoshii; Natsuo Oka; Hidenori Inohara; Hyeong-Reh Choi Kim; Robert S Bresalier; Avraham Raz
Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs.
Molecular and cellular biology 2004;24(10):4395-406.
2004: Suresh Mishra; Avraham Raz; Liam J Murphy
Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function.
Cancer research 2004;64(7):2516-22.
2004: Yves A DeClerck; Arthur M Mercurio; M Sharon Stack; Harold A Chapman; Mary M Zutter; Ruth J Muschel; Avraham Raz; Lynn M Matrisian; Bonnie F Sloane; Agnes Noel; Mary J Hendrix; Lisa M Coussens; Martin Padarathsingh
Proteases, extracellular matrix, and cancer: a workshop of the path B study section.
The American journal of pathology 2004;164(4):1131-9.
2004: Yukinori Takenaka; Tomoharu Fukumori; Avraham Raz
Galectin-3 and metastasis.
Glycoconjugate journal 2004;19(7-9):543-9.
2004: Natsuo Oka; Yukinori Takenaka; Avraham Raz
Galectins and urological cancer.
Journal of cellular biochemistry 2004;91(1):118-24.
2003: Arayo Haga; Tatsuyoshi Funasaka; Yasufumi Niinaka; Avraham Raz; Hisamitsu Nagase
Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression.
International journal of cancer. Journal international du cancer 2003;107(5):707-14.
2003: Tomoharu Fukumori; Yukinori Takenaka; Tadashi Yoshii; Hyeong-Reh Choi Kim; Victor Hogan; Hidenori Inohara; Susumu Kagawa; Avraham Raz
CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis.
Cancer research 2003;63(23):8302-11.
2003: Sándor Paku; József Tóvári; Zsolt Lörincz; Ferenc Timár; Balázs Döme; László Kopper; Avraham Raz; József Tímár
Adhesion dynamics and cytoskeletal structure of gliding human fibrosarcoma cells: a hypothetical model of cell migration.
Experimental cell research 2003;290(2):246-53.
2003: Soichi Tsutsumi; Takashi Yanagawa; Tatsuo Shimura; Tomoharu Fukumori; Victor Hogan; Hiroyuki Kuwano; Avraham Raz
Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
The Journal of biological chemistry 2003;278(34):32165-72.
2003: Yukinori Takenaka; Hidenori Inohara; Tadashi Yoshii; Kazuo Oshima; Susumu Nakahara; Shiro Akahani; Yuichiro Honjo; Yoshifumi Yamamoto; Avraham Raz; Takeshi Kubo
Malignant transformation of thyroid follicular cells by galectin-3.
Cancer letters 2003;195(1):111-9.
2003: Dominik Riss; Long Jin; Xiang Qian; Jill Bayliss; Bernd W Scheithauer; William F Young; Sergio Vidal; Kalman Kovacs; Avraham Raz; Ricardo V Lloyd
Differential expression of galectin-3 in pituitary tumors.
Cancer research 2003;63(9):2251-5.
2003: Soichi Tsutsumi; Suresh K Gupta; Victor Hogan; Nobutada Tanaka; Kazuo T Nakamura; Ivan R Nabi; Avraham Raz
The enzymatic activity of phosphoglucose isomerase is not required for its cytokine function.
FEBS letters 2003;534(1-3):49-53.
2003: Yasuharu Onishi; Kazuhiro Tsukada; Jun Yokota; Avraham Raz
Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation.
Clinical & experimental metastasis 2003;20(1):51-8.
2003: Soichi Tsutsumi; Victor Hogan; Ivan R Nabi; Avraham Raz
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Cancer research 2003;63(1):242-9.
2002: Pratima Nangia-Makker; Victor Hogan; Yuichiro Honjo; Sara Baccarini; Larry Tait; Robert S Bresalier; Avraham Raz
Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
Journal of the National Cancer Institute 2002;94(24):1854-62.
2002: Huei-Min Lin; Richard G Pestell; Avraham Raz; Hyeong-Reh Choi Kim
Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells.
Oncogene 2002;21(52):8001-10.
2002: Amjad H Talukder; Rozita Bagheri-Yarmand; Ruth R E Williams; Jiannis Ragoussis; Rakesh Kumar; Avraham Raz
Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3285-9.
2002: Tatsuyoshi Funasaka; Arayo Haga; Avraham Raz; Hisamitsu Nagase
Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
International journal of cancer. Journal international du cancer 2002;101(3):217-23.
2002: Soichi Tsutsumi; Suresh K Gupta; Victor Hogan; John G Collard; Avraham Raz
Activation of small GTPase Rho is required for autocrine motility factor signaling.
Cancer research 2002;62(15):4484-90.
2002: H Niizeki; Masanobu Kobayashi; Iori Horiuchi; N Akakura; Jian Chen; Jingxin Wang; J-i Hamada; P Seth; Hiroyuki Katoh; H Watanabe; Avraham Raz; Masuo Hosokawa
Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells.
British journal of cancer 2002;86(12):1914-9.
2002: Nobutada Tanaka; Arayo Haga; Hiroshi Uemura; Hiroko Akiyama; Tatsuyoshi Funasaka; Hisamitsu Nagase; Avraham Raz; Kazuo T Nakamura
Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.
Journal of molecular biology 2002;318(4):985-97.
2002: Fei Yu; Russell L Finley; Avraham Raz; Hyeong-Reh Choi Kim
Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation.
The Journal of biological chemistry 2002;277(18):15819-27.
2002: Tatsuyoshi Funasaka; Arayo Haga; Avraham Raz; Hisamitsu Nagase
Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
Biochemical and biophysical research communications 2002;293(1):192-200.
2002: Thomas Otto; G Luemmen; A Bex; Julia Suhr; Peter J Goebell; Avraham Raz; H Ruebben
Tumor cell motility as a novel target in cancer--experimental and clinical results.
Onkologie 2002;25(2):172-7.
2002: Pratima Nangia-Makker; Jeffrey Conklin; Victor Hogan; Avraham Raz
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents.
Trends in molecular medicine 2002;8(4):187-92.
2002: Tadashi Yoshii; Tomoharu Fukumori; Yuichiro Honjo; Hidenori Inohara; Hyeong-Reh Choi Kim; Avraham Raz
Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest.
The Journal of biological chemistry 2002;277(9):6852-7.
2002: József Tímár; Erzsébet Rásó; Balázs Döme; Andrea Ladányi; Teodóra Bánfalvi; Katalin Gilde; Avraham Raz
Expression and function of the AMF receptor by human melanoma in experimental and clinical systems.
Clinical & experimental metastasis 2002;19(3):225-32.
2002: Yongquan Luo; Jeffrey M Long; Chengbiao Lu; Sic L Chan; Edward L Spangler; Paolo Mascarucci; Avraham Raz; Dan Longo; Mark P Mattson; Donald Ingram; Nan-ping Weng
A link between maze learning and hippocampal expression of neuroleukin and its receptor gp78.
Journal of neurochemistry 2002;80(2):354-61.
2002: Yasufumi Niinaka; Arayo Haga; Akihide Negishi; Hidemi Yoshimasu; Avraham Raz; Teruo Amagasa
Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Oral oncology 2002;38(1):49-55.
2001: Iwao Takanami; Ken Takeuchi; Hideomi Watanabe; T Yanagawa; K Takagishi; Avraham Raz
Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
International journal of cancer. Journal international du cancer 2001;95(6):384-7.
2001: BK Moon; Yong J Lee; Paul Battle; J Milburn Jessup; Avraham Raz; Hyeong-Reh Choi Kim
Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis.
The American journal of pathology 2001;159(3):1055-60.
2001: Tatsuyoshi Funasaka; Arayo Haga; Avraham Raz; Hisamitsu Nagase
Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Biochemical and biophysical research communications 2001;285(1):118-28.
2001: Tatsuyoshi Funasaka; Arayo Haga; Avraham Raz; Hisamitsu Nagase
Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Biochemical and biophysical research communications 2001;284(5):1116-25.
2001: Tadashi Yoshii; Hidenori Inohara; Yukinori Takenaka; Yuichiro Honjo; Shiro Akahani; T Nomura; Avraham Raz; Tateki Kubo
Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells.
International journal of oncology 2001;18(4):787-92.
2001: Yuichiro Honjo; Pratima Nangia-Makker; Hidenori Inohara; Avraham Raz
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3):661-8.
2001: Pratima Nangia-Makker; Yuichiro Honjo; Avraham Raz
Galectin-3 binding and metastasis.
Methods in molecular medicine 2001;58():149-57.
2001: Yasufumi Niinaka; A Haga; Avraham Raz
Quantification of cell motility : gold colloidal phagokinetic track assay and wound healing assay.
Methods in molecular medicine 2001;58():55-60.
2001: Elieser Gorelik; Uri Galili; Avraham Raz
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis.
Cancer metastasis reviews 2001;20(3-4):245-77.
2000: Yuichiro Honjo; Hidenori Inohara; Shiro Akahani; Tadashi Yoshii; Yukinori Takenaka; Jun-ichi Yoshida; K Hattori; Y Tomiyama; Avraham Raz; Tateki Kubo
Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4635-40.
2000: Nachman Mazurek; J Conklin; James C Byrd; Avraham Raz; Robert S Bresalier
Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands.
The Journal of biological chemistry 2000;275(46):36311-5.
2000: Phuong U Le; Naciba Benlimame; Annick Lagana; Avraham Raz; Ivan R Nabi
Clathrin-mediated endocytosis and recycling of autocrine motility factor receptor to fibronectin fibrils is a limiting factor for NIH-3T3 cell motility.
Journal of cell science 2000;113 ( Pt 18)():3227-40.
2000: Arayo Haga; Yasufumi Niinaka; Avraham Raz
Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.
Biochimica et biophysica acta 2000;1480(1-2):235-44.
2000: R A Pacis; MJ Pilat; Kenneth J Pienta; K Wojno; Avraham Raz; V Hogan; Carlton R Cooper
Decreased galectin-3 expression in prostate cancer.
The Prostate 2000;44(2):118-23.
2000: Annick Lagana; T Duchaine; Avraham Raz; Luc DesGroseillers; Ivan R Nabi
Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
Biochemical and biophysical research communications 2000;273(1):213-8.
2000: Pratima Nangia-Makker; Yuichiro Honjo; R Sarvis; Shiro Akahani; Victor Hogan; Kenneth J Pienta; Avraham Raz
Galectin-3 induces endothelial cell morphogenesis and angiogenesis.
The American journal of pathology 2000;156(3):899-909.
2000: Amjad H Talukder; Liana Adam; Avraham Raz; Rakesh Kumar
Heregulin regulation of autocrine motility factor expression in human tumor cells.
Cancer research 2000;60(2):474-80.
2000: Pratima Nangia-Makker; S Baccarini; Avraham Raz
Carbohydrate-recognition and angiogenesis.
Cancer metastasis reviews 2000;19(1-2):51-7.
1999: H C Gong; Yuichiro Honjo; Pratima Nangia-Makker; Victor Hogan; N Mazurak; Robert S Bresalier; Avraham Raz
The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
Cancer research 1999;59(24):6239-45.
1999: Hyeong-Reh Choi Kim; Huei-Min Lin; Hector Biliran; Avraham Raz
Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells.
Cancer research 1999;59(16):4148-54.
1999: K Shimizu; M Tani; H Watanabe; Y Nagamachi; Y Niinaka; T Shiroishi; S Ohwada; Avraham Raz; J Yokota
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein.
FEBS letters 1999;456(2):295-300.
1999: Hidenori Inohara; Yuichiro Honjo; Tadashi Yoshii; Shiro Akahani; Jun-ichi Yoshida; K Hattori; S Okamoto; T Sawada; Avraham Raz; Tateki Kubo
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Cancer 1999;85(11):2475-84.
1999: J Timár; S Tóth; József Tóvári; Sándor Paku; Avraham Raz
Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Clinical & experimental metastasis 1999;17(10):809-16.
1999: Thomas Otto; Gerd Lümmen; A Be; Herbert Rübben; Avraham Raz
Tumor cell motility. A novel therapeutic target in bladder carcinoma, experimental and clinical results.
Advances in experimental medicine and biology 1999;462():469-76.
1998: Hidenori Inohara; Shiro Akahani; Avraham Raz
Galectin-3 stimulates cell proliferation.
Experimental cell research 1998;245(2):294-302.
1998: Robert S Bresalier; Nachman Mazurek; Lawrence R Sternberg; James C Byrd; Christopher K Yunker; Pratima Nangia-Makker; Avraham Raz
Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3.
Gastroenterology 1998;115(2):287-96.
1998: Yasufumi Niinaka; Sándor Paku; Arayo Haga; Hideomi Watanabe; Avraham Raz
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
Cancer research 1998;58(12):2667-74.
1998: Pratima Nangia-Makker; R Sarvis; Daniel W Visscher; J Bailey-Penrod; Avraham Raz; Asfar S Azmi
Galectin-3 and L1 retrotransposons in human breast carcinomas.
Breast cancer research and treatment 1998;49(2):171-83.
1998: Steven A. Silletti; Sándor Paku; Avraham Raz
Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells.
International journal of cancer. Journal international du cancer 1998;76(1):129-35.
1998: Steven A. Silletti; Sándor Paku; Avraham Raz
Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization.
International journal of cancer. Journal international du cancer 1998;76(1):120-8.
1998: Iwao Takanami; Ken Takeuchi; M Naruke; Susumu Kodaira; F Tanaka; Hideomi Watanabe; Avraham Raz
Autocrine motility factor in pulmonary adenocarcinomas: results of an immunohistochemical study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1998;19(5):384-9.
1997: Shiro Akahani; Pratima Nangia-Makker; Hidenori Inohara; Hyeong-Reh Choi Kim; Avraham Raz
Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family.
Cancer research 1997;57(23):5272-6.
1997: I Takanami; S Kodaira; F Tanaka; H Watanabe; Avraham Raz
Autocrine motility factor receptor expression as a prognostic factor in pulmonary adenocarcinoma.
Oncology reports 1997;4(5):949-51.
1997: Steven A. Silletti; Sándor Paku; Avraham Raz
Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.
Pathology oncology research : POR 1997;3(3):230-54.
1997: R S Bresalier; P S Yan; J C Byrd; R Lotan; Avraham Raz
Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system.
Cancer 1997;80(4):776-87.
1997: Thomas Otto; Axel Bex; U Schmidt; Avraham Raz; Herbert Rübben
Improved prognosis assessment for patients with bladder carcinoma.
The American journal of pathology 1997;150(6):1919-23.
1997: PR Warfield; P N Makker; Avraham Raz; Josiah Ochieng
Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3.
Invasion & metastasis 1997;17(2):101-12.
1997: Steven A. Silletti; Jozsef Timar; Kenneth V Honn; Avraham Raz
Regulation of tumor cell motility by 12(S)-HETE.
Advances in experimental medicine and biology 1997;400B():683-92.
1996: Y Hirono; Sachio Fushida; Yutaka Yonemura; H Yamamoto; H Watanabe; Avraham Raz
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
British journal of cancer 1996;74(12):2003-7.
1996: David C Gervasi; Avraham Raz; M Dehem; M Yang; Markku T Kurkinen; Rafael Fridman
Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells.
Biochemical and biophysical research communications 1996;228(2):530-8.
1996: József Tímár; Erzsébet Rásó; Z S Fazakas; Steven A. Silletti; Avraham Raz; Kenneth V Honn
Multiple use of a signal transduction pathway in tumor cell invasion.
Anticancer research 1996;16(6A):3299-306.
1996: Hidenori Inohara; Shiro Akahani; K Koths; Avraham Raz
Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
Cancer research 1996;56(19):4530-4.
1996: Robert S Bresalier; James C Byrd; L Wang; Avraham Raz
Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Cancer research 1996;56(19):4354-7.
1996: Y Niinaka; S Oida; A Ishisaki; K Takeda; T Iimura; Y Maruoka; F Momose; A Negishi; H Ichijo; T Amagasa; S Sasaki; H Watanabe; Avraham Raz
Autocrine motility factor and its receptor expressions in human oral squamous cell carcinoma (SCC) cells.
International journal of oncology 1996;9(3):433-8.
1996: Frank D Yelian; A Liu; Jill C Todt; J Lei; Faisal Qureshi; Suzanne M Jacques; Gunter Deppe; Avraham Raz
Expression and function of autocrine motility factor receptor in human choriocarcinoma.
Gynecologic oncology 1996;62(2):159-165.
1996: Hideomi Watanabe; K Takehana; M Date; Tetsuya Shinozaki; Avraham Raz
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Cancer research 1996;56(13):2960-3.
1996: Steven A. Silletti; Sándor Paku; Avraham Raz
Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
The American journal of pathology 1996;148(5):1649-60.
1996: Jozsef Timar; Mohit Trikha; K Szekeres; R Bazaz; J Tovari; Steven A. Silletti; Avraham Raz; Kenneth V Honn
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Cancer research 1996;56(8):1902-8.
1996: Steven A. Silletti; Avraham Raz
Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis.
Current topics in microbiology and immunology 1996;213 ( Pt 2)():137-69.
1996: H J Korman; James O Peabody; J C Cerny; R N Farah; J Yao; Avraham Raz
Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
The Journal of urology 1996;155(1):347-9.
1995: L Wang; H Inohara; Kenneth J Pienta; Avraham Raz
Galectin-3 is a nuclear matrix protein which binds RNA.
Biochemical and biophysical research communications 1995;217(1):292-303.
1995: P Nangiamakker; E Thompson; C Hogan; Josiah Ochieng; Avraham Raz
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line.
International journal of oncology 1995;7(5):1079-87.
1995: K Maruyama; H Watanabe; Hitoshi Shiozaki; T Takayama; J Gofuku; H Yano; M Inoue; S Tamura; Avraham Raz; Morito Monden
Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma.
International journal of cancer. Journal international du cancer 1995;64(5):316-21.
1995: Steven A. Silletti; J P Yao; Kenneth J Pienta; Avraham Raz
Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
International journal of cancer. Journal international du cancer 1995;63(1):100-5.
1995: Hidenori Inohara; Avraham Raz
Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion.
Cancer research 1995;55(15):3267-71.
1995: B Huang; Y Xie; Avraham Raz
Identification of an upstream region that controls the transcription of the human autocrine motility factor receptor.
Biochemical and biophysical research communications 1995;212(3):727-42.
1995: H L Schoeppner; Avraham Raz; Samuel B Ho; Robert S Bresalier
Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.
Cancer 1995;75(12):2818-26.
1995: Kenneth J Pienta; H Naik; A Akhtar; K Yamazaki; T S Replogle; jeffrey lehr; T L Donat; Larry Tait; V Hogan; Avraham Raz
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.
Journal of the National Cancer Institute 1995;87(5):348-53.
1994: H Inohara; Avraham Raz
Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions.
Glycoconjugate journal 1994;11(6):527-32.
1994: Josiah Ochieng; Rafael Fridman; Pratima Nangia-Makker; D E Kleiner; L A Liotta; William Stetler-Stevenson; Avraham Raz
Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
Biochemistry 1994;33(47):14109-14.
1994: Steven A. Silletti; Jozsef Timar; Kenneth V Honn; Avraham Raz
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Cancer research 1994;54(22):5752-6.
1994: S Nakamori; H Watanabe; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; Avraham Raz
Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
Cancer 1994;74(7):1855-62.
1994: H Inohara; Avraham Raz
Identification of human melanoma cellular and secreted ligands for galectin-3.
Biochemical and biophysical research communications 1994;201(3):1366-75.
1994: Thomas Otto; W Birchmeier; U Schmidt; A Hinke; J Schipper; Herbert Rübben; Avraham Raz
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Cancer research 1994;54(12):3120-3.
1994: A Isoai; H Goto-Tsukamoto; T Yamori; T Oh-hara; T Tsuruo; Steven A. Silletti; Avraham Raz; H Watanabe; Hitoshi Akedo; H Kumagai
Inhibitory effects of tumor invasion-inhibiting factor 2 and its conjugate on disseminating tumor cells.
Cancer research 1994;54(5):1264-70.
1993: Jozsef Timar; Steven A. Silletti; R Bazaz; Avraham Raz; Kenneth V Honn
Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
International journal of cancer. Journal international du cancer 1993;55(6):1003-10.
1993: S Silletti; J Yao; J Sanford; A Mohammed; T Otto; S Wolman; Avraham Raz
Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mapping.
International journal of oncology 1993;3(5):801-7.
1993: Pratima Nangia-Makker; Josiah Ochieng; J K Christman; Avraham Raz
Regulation of the expression of galactoside-binding lectin during human monocytic differentiation.
Cancer research 1993;53(20):5033-7.
1993: Steven A. Silletti; Avraham Raz
Autocrine motility factor is a growth factor.
Biochemical and biophysical research communications 1993;194(1):446-57.
1993: Josiah Ochieng; D Platt; Larry Tait; V Hogan; T Raz; Pnina Carmi; Avraham Raz
Structure-function relationship of a recombinant human galactoside-binding protein.
Biochemistry 1993;32(16):4455-60.
1993: Hideomi Watanabe; Tetsuya Shinozaki; Avraham Raz; M Chigira
Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis.
International journal of cancer. Journal international du cancer 1993;53(4):689-95.
1993: Hideomi Watanabe; M Chigira; Avraham Raz
[The role of autocrine motility factor receptor in metastasis].
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(3):405-9.
1992: Reuben Lotan; B Amos; H Watanabe; Avraham Raz
Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Cancer research 1992;52(18):4878-84.
1992: Josiah Ochieng; M Gerold; Avraham Raz
Dichotomy in the laminin-binding properties of soluble and membrane-bound human galactoside-binding protein.
Biochemical and biophysical research communications 1992;186(3):1674-80.
1992: D Platt; Avraham Raz
Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin.
Journal of the National Cancer Institute 1992;84(6):438-42.
1992: I R Nabi; H Watanabe; Avraham Raz
Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Cancer metastasis reviews 1992;11(1):5-20.
1991: H Watanabe; Pnina Carmi; V Hogan; T Raz; Steven A. Silletti; I R Nabi; Avraham Raz
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.
The Journal of biological chemistry 1991;266(20):13442-8.
1991: Steven A. Silletti; H Watanabe; V Hogan; I R Nabi; Avraham Raz
Purification of B16-F1 melanoma autocrine motility factor and its receptor.
Cancer research 1991;51(13):3507-11.
1991: H Watanabe; I R Nabi; Avraham Raz
The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells.
Cancer research 1991;51(10):2699-705.
1991: Avraham Raz; Pnina Carmi; T Raz; V Hogan; Anwar N Mohamed; Sandra R Wolman
Molecular cloning and chromosomal mapping of a human galactoside-binding protein.
Cancer research 1991;51(8):2173-8.
1991: Josiah Ochieng; F Basolo; Adriana Albini; A Melchiori; H Watanabe; J Elliott; Avraham Raz; Stefano Parodi; J Russo
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells.
Invasion & metastasis 1991;11(1):38-47.
1991: I R Nabi; H Watanabe; Steven A. Silletti; Avraham Raz
Tumor cell autocrine motility factor receptor.
EXS 1991;59():163-77.
1990: Avraham Raz; D G Zhu; V Hogan; N Shah; T Raz; R Karkash; G Pazerini; Pnina Carmi
Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis.
International journal of cancer. Journal international du cancer 1990;46(5):871-7.
1990: I R Nabi; H Watanabe; Avraham Raz
Identification of B16-F1 melanoma autocrine motility-like factor receptor.
Cancer research 1990;50(2):409-14.
1989: Avraham Raz; G Pazerini; Pnina Carmi
Identification of the metastasis-associated, galactoside-binding lectin as a chimeric gene product with homology to an IgE-binding protein.
Cancer research 1989;49(13):3489-93.
1989: D Linnemann; Avraham Raz; Elisabeth Bock
Differential expression of cell adhesion molecules in variants of K1735 melanoma cells differing in metastatic capacity.
International journal of cancer. Journal international du cancer 1989;43(4):709-12.
1989: Reuben Lotan; D Carralero; Dafna Lotan; Avraham Raz
Biochemical and immunological characterization of K-1735P melanoma galactoside-binding lectins and their modulation by differentiation inducers.
Cancer research 1989;49(5):1261-8.
1988: Reuben Lotan; Avraham Raz
Endogenous lectins as mediators of tumor cell adhesion.
Journal of cellular biochemistry 1988;37(1):107-17.
1988: I R Nabi; Avraham Raz
Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
Cancer research 1988;48(5):1258-64.
1988: Margot Zöller; A Strubel; G Hämmerling; G Andrighetto; Avraham Raz; A Ben-Ze'ev
Interferon-gamma treatment of B16 melanoma cells: opposing effects for non-adaptive and adaptive immune defense and its reflection by metastatic spread.
International journal of cancer. Journal international du cancer 1988;41(2):256-66.
1988: Avraham Raz; Pnina Carmi; G Pazerini
Expression of two different endogenous galactoside-binding lectins sharing sequence homology.
Cancer research 1988;48(3):645-9.
1988: Avraham Raz
Adhesive properties of metastasizing tumour cells.
Ciba Foundation symposium 1988;141():109-22.
1988: Reuben Lotan; Avraham Raz
Lectins in cancer cells.
Annals of the New York Academy of Sciences 1988;551():385-96; discussion 396-8.
1988: Avraham Raz
Actin organization, cell motility, and metastasis.
Advances in experimental medicine and biology 1988;233():227-33.
1987: Avraham Raz; A Avivi; G Pazerini; Pnina Carmi
Cloning and expression of cDNA for two endogenous UV-2237 fibrosarcoma lectin genes.
Experimental cell research 1987;173(1):109-16.
1987: I R Nabi; Avraham Raz
Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen.
International journal of cancer. Journal international du cancer 1987;40(3):396-402.
1987: Avraham Raz; L Meromsky; Isabel Zvibel; R Lotan
Transformation-related changes in the expression of endogenous cell lectins.
International journal of cancer. Journal international du cancer 1987;39(3):353-60.
1987: Avraham Raz; R Lotan
Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis.
Cancer metastasis reviews 1987;6(3):433-52.
1987: Avraham Raz; A Ben-Ze'ev
Cell-contact and -architecture of malignant cells and their relationship to metastasis.
Cancer metastasis reviews 1987;6(1):3-21.
1986: L Meromsky; R Lotan; Avraham Raz
Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization.
Cancer research 1986;46(10):5270-5.
1986: Avraham Raz; L Meromsky; R Lotan
Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic, and metastatic cells.
Cancer research 1986;46(7):3667-72.
1986: A Ben-Ze'ev; M Zöller; Avraham Raz
Differential expression of intermediate filament proteins in metastatic and nonmetastatic variants of the BSp73 tumor.
Cancer research 1986;46(2):785-90.
1986: Avraham Raz; M Zöller
Cell configuration and adhesive properties of metastasizing and non-metastasizing BSp73 rat adenocarcinoma cells.
Experimental cell research 1986;162(1):127-41.
1985: R Lotan; D Lotan; Avraham Raz
Inhibition of tumor cell colony formation in culture by a monoclonal antibody to endogenous lectins.
Cancer research 1985;45(9):4349-53.
1985: Isabel Zvibel; Avraham Raz
The establishment and characterization of a new BALB/c angiosarcoma tumor system.
International journal of cancer. Journal international du cancer 1985;36(2):261-72.
1985: A Ben-Ze'ev; Avraham Raz
Relationship between the organization and synthesis of vimentin and the metastatic capability of B16 melanoma cells.
Cancer research 1985;45(6):2632-41.
1985: R M Kris; A Avivi; M Bar-Eli; Y Alon; Pnina Carmi; J Schlessinger; Avraham Raz
Expression of ki-ras oncogene in tumor cell variants exhibiting different metastatic capabilities.
International journal of cancer. Journal international du cancer 1985;35(2):227-30.
1984: D Eliyahu; Avraham Raz; P Gruss; D Givol; M Oren
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.
Nature 1984;312(5995):646-9.
1984: Avraham Raz; L Meromsky; P Carmi; R Karakash; D Lotan; R Lotan
Monoclonal antibodies to endogenous galactose-specific tumor cell lectins.
The EMBO journal 1984;3(12):2979-83.
1984: S Reich; H Rosin; M Levy; R Karkash; Avraham Raz
Cell-substrate interaction. A method for evaluating the possible correlation between metastatic phenotype and cell surface energy.
Experimental cell research 1984;153(2):556-60.
1984: T Volk; B Geiger; Avraham Raz
Motility and adhesive properties of high- and low-metastatic murine neoplastic cells.
Cancer research 1984;44(2):811-24.
1984: Avraham Raz
The demonstration of nonlinear development of experimental lung tumor metastases.
Clinical & experimental metastasis 1984;2(1):5-13.
1983: Avraham Raz; A Ben-Ze'ev
Modulation of the metastatic capability in B16 melanoma by cell shape.
Science (New York, N.Y.) 1983;221(4617):1307-10.
1983: Avraham Raz
[The biological heterogeneity of malignant tumors].
Harefuah 1983;104(10):458-60.
1983: R Lotan; Avraham Raz
Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation.
Cancer research 1983;43(5):2088-93.
1982: Avraham Raz; B Geiger
Altered organization of cell-substrate contacts and membrane-associated cytoskeleton in tumor cell variants exhibiting different metastatic capabilities.
Cancer research 1982;42(12):5183-90.
1982: Avraham Raz
Regional emergence of metastatic heterogeneity in a growing tumor.
Cancer letters 1982;17(2):153-60.
1982: Avraham Raz; A Ben-Ze'ev
Growth control and cell spreading: differential response in preneoplastic and in metastatic cell variants.
International journal of cancer. Journal international du cancer 1982;29(6):711-5.
1982: G Poste; C Bucana; Avraham Raz; P Bugelski; R Kirsh; I J Fidler
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.
Cancer research 1982;42(4):1412-22.
1982: Avraham Raz
B16 melanoma cell variants: irreversible inhibition of growth and induction of morphologic differentiation by anthracycline antibiotics.
Journal of the National Cancer Institute 1982;68(4):629-38.
1981: A Ben-Ze'ev; Avraham Raz
Multinucleation and inhibition of cytokinesis in suspended cells: reversal upon reattachment to a substrate.
Cell 1981;26(1 Pt 1):107-15.
1981: Avraham Raz; R Lotan
Lectin-like activities associated with human and murine neoplastic cells.
Cancer research 1981;41(9 Pt 1):3642-7.
1981: Avraham Raz; C Bucana; W E Fogler; G Poste; I J Fidler
Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages.
Cancer research 1981;41(2):487-94.
1981: I J Fidler; Avraham Raz; W E Fogler; L C Hoyer; G Poste
The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Cancer research 1981;41(2):495-504.
1981: Avraham Raz; N Hanna; I J Fidler
In vivo isolation of a metastatic tumor cell variant involving selective and nonadaptive processes.
Journal of the National Cancer Institute 1981;66(1):183-9.
1980: I J Fidler; Avraham Raz; W E Fogler; R Kirsh; P Bugelski; G Poste
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
Cancer research 1980;40(12):4460-6.
1980: Avraham Raz; I R Hart
Murine melanoma: a model for intracranial metastasis.
British journal of cancer 1980;42(2):331-41.
1980: W E Fogler; Avraham Raz; I J Fidler
In situ activation of murine macrophages by liposomes containing lymphokines.
Cellular immunology 1980;53(1):214-9.
1980: Avraham Raz; W L McLellan; I R Hart; C D Bucana; L C Hoyer; B A Sela; P Dragsten; I J Fidler
Cell surface properties of B16 melanoma variants with differing metastatic potential.
Cancer research 1980;40(5):1645-51.
1980: Avraham Raz; C Bucana
The redistribution of membrane surface immunoglobulin induces the rearrangement of some membrane integral proteins.
Biochimica et biophysica acta 1980;597(3):615-21.
1980: I R Hart; Avraham Raz; I J Fidler
Effect of cytoskeleton-disrupting agents on the metastatic behavior of melanoma cells.
Journal of the National Cancer Institute 1980;64(4):891-900.
1980: Avraham Raz; C Bucana; W McLellan; I J Fidler
Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential.
Nature 1980;284(5754):363-4.
1980: I J Fidler; Avraham Raz; W E Fogler; G Poste
Pulmonary localization of intravenously injected liposomes.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1980;75():246-51.
1979: Z Bar-Shavit; Avraham Raz; R Goldman
Complement and Fc receptor-mediated phagocytosis of normal and stimulated mouse peritoneal macrophages.
European journal of immunology 1979;9(5):385-91.
1979: R Goldman; Z Bar-Shavit; Avraham Raz
Functional similarity and diversity in peritoneal macrophage populations induced in vivo by various stimuli.
Advances in experimental medicine and biology 1979;121(A):323-32.
1978: T Facchinetti; Avraham Raz; R Goldman
A differential interaction of daunomycin, adriamycin, and N-trifluoroacetyladriamycin 14-valerate with mouse peritoneal macrophages.
Cancer research 1978;38(11 Pt 1):3944-9.
1978: R Goldman; T Facchinetti; D Bach; Avraham Raz; M Shinitzky
A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayers.
Biochimica et biophysica acta 1978;512(2):254-69.
1978: Avraham Raz; R Barzilai; G Spira; M Inbar
Oncogenicity and immunogenicity associated with membranes isolated from cell-free ascites fluid of lymphoma-bearing mice.
Cancer research 1978;38(8):2480-5.
1978: Avraham Raz; J G Collard; M Inbar
Decrease in 5'-nucleotidase activity in malignant transformed and normal stimulated cells.
Cancer research 1978;38(5):1258-62.
1977: Avraham Raz; A Shahar; R Goldman
Characterization of an in vivo induced peritoneal macrophage population following intraperitoneal injection of concanavalin A.
Journal of the Reticuloendothelial Society 1977;22(5):445-60.
1977: Avraham Raz; M Inbar; R Goldman
A differential interaction in vitro of mouse macrophages with normal lymphocytes and malignant lymphoma cells.
European journal of cancer 1977;13(6):605-15.
1976: Avraham Raz; R Goldman
Effects of local anaesthetics on intracellular fusion processes. Enhancement of concanavalin A-induced macrophage vacuolation.
Biochimica et biophysica acta 1976;455(1):226-40.
1976: Avraham Raz; R Goldman
The in vitro effect of hydrocortisone on endocytosis in cultured mouse peritoneal macrophages.
Journal of the Reticuloendothelial Society 1976;20(3):177-86.
1976: D Bach; Avraham Raz; R Goldman
The effect of hashish compounds on pphospholipid phase transition.
Biochimica et biophysica acta 1976;436(4):889-94.
1976: D Bach; Avraham Raz; R Goldman
The interaction of hashish compounds with planar lipid bilayer membranes (BLM).
Biochemical pharmacology 1976;25(11):1241-4.
1976: Avraham Raz; R Goldman
Differential effects of lipids on the osmotic fragility of lysosomes.
Experientia 1976;32(4):447-9.
1976: Avraham Raz; R Goldman
Effect of hashish compounds on mouse peritoneal macrophages.
Laboratory investigation; a journal of technical methods and pathology 1976;34(1):69-76.
1975: R Goldman; Avraham Raz
Concanavalin A and the in vitro induction in macrophages of vacuolation and lysosomal enzyme synthesis.
Experimental cell research 1975;96(2):393-405.
1975: Avraham Raz; R Goldman
Proceedings: Effect of hashish compounds on mouse peritoneal macrophages.
Israel journal of medical sciences 1975;11(11):1177.
1974: Avraham Raz; R Goldman
Spontaneous fusion of rat liver lysosomes in vitro.
Nature 1974;247(438):206-8.
1973: Avraham Raz; Avital Schurr; A Livne; R Goldman
Effect of hashish compounds on rat liver lysosomes in vitro.
Biochemical pharmacology 1973;22(23):3129-31.
1973: Avraham Raz; A Livne
Differential effects of lipids on the osmotic fragility of erythrocytes.
Biochimica et biophysica acta 1973;311(2):222-9.